The effect of berberine on the symptoms of patients with schizophrenia
Phase 2
Recruiting
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT20190726044339N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Having schizophrenia
Received antipsychotic medication in the last three months
Exclusion Criteria
Having other psychiatric disorder
Pregnancy and lactation
Receive concomitant ECT
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in PANSS questionnaire score (positive and negative symptom scale). Timepoint: One month. Method of measurement: PANSS( positive and negative symptom scale).
- Secondary Outcome Measures
Name Time Method